ongoing lawsuits related to Avandia. Since then, only the name has changed.
Status: Withdrawn from the market in France since June 9, 2011, due to an increased risk of bladder cancer confirmed by epidemiological studies.
– ADARTREL
Indications: restless legs syndrome, disturbed sleep.
Side effects: nausea, impulsive behavior, increased libido, hallucinations, paranoia, fainting.
Status: Authorised in France (last updated 2025), without specific restrictions beyond the usual precautions for dopaminergic agonists.
– HEXAQUINE
Indications: muscle cramps.
Side effects: heart rhythm disorders, decreased platelet count, severe allergic reactions (15%).
Status: Authorised in France (last